BDX vs TMO
BDX: BD is a leading global medical technology company providing essential medical devices, diagnostic systems, and laboratory solutions to healthcare providers and researchers worldwide. TMO: Thermo Fisher Scientific is a global leader in serving science, providing an extensive portfolio of analytical instruments, laboratory equipment, and mission-critical consumables for the life sciences and healthcare industries.
Side-by-side fundamentals
| Metric | BDX | TMO | Edge |
|---|---|---|---|
| Price as of 2026-07-27 close | $158.92 | $559.53 | |
| Market cap as of 2026-07-31 | $43.8B | $207.9B | |
| P/E as of 2026-07-31 | 40.01 | 30.20 | TMO lower |
| PEG as of 2026-07-31 | -20.92 | 2.89 | BDX lower |
| Net margin as of 2026-07-31 | +5.3% | +15.0% | TMO higher |
| Gross margin as of 2026-07-31 | +47.0% | +40.9% | BDX higher |
| Operating margin as of 2026-07-31 | +10.2% | +17.6% | TMO higher |
| ROE as of 2026-07-31 | +4.5% | +13.3% | TMO higher |
| ROA as of 2026-07-31 | +2.1% | +6.3% | TMO higher |
| Debt / equity as of 2026-07-31 | 0.72 | 0.81 | BDX lower |
| Revenue growth (YoY) as of 2026-07-31 | +2.4% | +7.2% | TMO higher |
| Revenue CAGR (3y) SEC XBRL | +5.0% | -0.3% | BDX higher |
| Dividend yield as of 2026-07-31 | +2.5% | +0.3% | BDX higher |
| Dividend streak (yrs) SEC XBRL | 5 | 5 | Tie |
| Beta as of 2026-07-31 | 0.20 | 0.82 | |
| 1-year return as of 2026-07-27 close | +9.1% | +17.0% | TMO higher |
Fundamentals: market data, as of 2026-07-31. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-27.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.